APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 51 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $120,000 | -52.8% | 442,619 | +34.0% | 0.00% | -50.0% |
| Q2 2022 | $254,000 | +0.4% | 330,287 | +39.8% | 0.00% | 0.0% |
| Q1 2022 | $253,000 | -5.2% | 236,335 | +68.3% | 0.00% | -20.0% |
| Q4 2021 | $267,000 | -40.1% | 140,389 | -5.2% | 0.01% | -44.4% |
| Q3 2021 | $446,000 | -34.8% | 148,058 | -15.4% | 0.01% | -35.7% |
| Q2 2021 | $684,000 | +13.2% | 174,908 | +46.9% | 0.01% | +7.7% |
| Q1 2021 | $604,000 | +26.6% | 119,048 | +2.1% | 0.01% | +18.2% |
| Q4 2020 | $477,000 | -19.4% | 116,592 | -4.2% | 0.01% | -26.7% |
| Q3 2020 | $592,000 | -14.5% | 121,746 | -2.5% | 0.02% | -25.0% |
| Q2 2020 | $692,000 | +60.6% | 124,874 | -5.1% | 0.02% | +42.9% |
| Q1 2020 | $431,000 | -28.3% | 131,526 | -1.1% | 0.01% | -6.7% |
| Q4 2019 | $601,000 | -5.8% | 132,944 | -13.4% | 0.02% | -25.0% |
| Q3 2019 | $638,000 | +4.6% | 153,468 | -4.7% | 0.02% | +5.3% |
| Q2 2019 | $610,000 | – | 160,975 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,404,515 | $1,081,000 | 2.01% |
| SABBY MANAGEMENT, LLC | 811,973 | $625,000 | 0.42% |
| Portolan Capital Management | 1,605,599 | $1,236,000 | 0.12% |
| Knoll Capital Management, LLC | 100,000 | $77,000 | 0.04% |
| Shay Capital LLC | 50,000 | $39,000 | 0.01% |
| COLONY GROUP LLC | 330,287 | $254,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 155,375 | $120,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,499,124 | $1,154,000 | 0.00% |
| Virtu Financial LLC | 10,807 | $8,000 | 0.00% |
| FIDUCIARY TRUST CO | 40,000 | $31,000 | 0.00% |